Human clinical trials for Covid-19 vaccine initiated in India: ICMR

Human clinical trials for Covid-19 vaccine initiated in India: ICMR

NEW DELHI: Human clinical trials for a vaccine for Covid-19 have been initiated in the country with approximately 1,000 volunteers participating in the exercise for each of the two indigenously developed vaccine candidates, the ICMR said on Tuesday.

Since India is one of the largest vaccine producers in the world, it is the country’s “moral responsibility” to fast-track vaccine development process to break the chain of


transmission, ICMR Director General Dr Balram Bhargava said, referring to the two vaccine candidates developed indigenously.

The Drugs Controller General of India (DCGI) has permitted two vaccines – one developed by

Bharat Biotech International

Limited in collaboration with the

Indian Council of Medical Research

and another one by Zydas

Cadila Healthcare

Ltd to go in for the first and second phase of human clinical trials.

There are two Indian vaccine candidates that have undergone successful toxicity studies in rats, mice and rabbits and these data was submitted to the DCGI, following which both got clearance to start an early phase human trials earlier this month, Bhargava said at a press briefing.

Read our coronavirus live blog for all the latest news and updates“Two indigenous Indian candidate vaccines have got clearance to start early phase human trials this month.

“They have got their sites ready and are doing the clinical study on approximately 1,000 human volunteers each at different sites. They are trying to do early clinical testing for these two indigenous vaccine candidates,” Bhargava said.

“… it is a moral duty to develop them as fast as possible because more than half a million people have succumbed to the disease across the world. So, fast-tracking these vaccine becomes very important,” he said.

A recent letter by Bhargava envisaging the launch of a Covid-19 vaccine by August 15 had created quite a flutter with many experts stating such a timeline may not be realistic.

Bhargava stated that India is considered as the “pharmacy of the world”, saying 60 per cent of the drugs utilised in the US are of

Indian origin


“The important fact that is not known is that 60 per cent of the vaccines supplied in the world whether it be


, Europe or Southeast Asia or any where are of Indian origin,” he said.

India is perceived and is an important player in the supply of vaccines for the world, Bhargava noted.

Coronavirus outbreak: Complete coverage“Any vaccine candidate that is produced or developed in any part of the world will ultimately have to be scaled up by India or by China because these two are major producers of vaccines in the world and that every developed nation or everyone trying to develop a vaccine are aware of it and therefore they are in communication with India for the vaccine distribution ultimately if is develo

Real More »